SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-17-002652
Filing Date
2017-05-11
Accepted
2017-05-11 17:23:56
Documents
41
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_033117.htm 10-Q 530420
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 11881
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 11304
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 5979
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 5875
  Complete submission text file 0001387131-17-002652.txt   1752230

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20170331.xml EX-101.INS 167543
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20170331.xsd EX-101.SCH 16310
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20170331_cal.xml EX-101.CAL 31968
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20170331_def.xml EX-101.DEF 71434
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20170331_lab.xml EX-101.LAB 162351
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20170331_pre.xml EX-101.PRE 131124
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 17835521
SIC: 2834 Pharmaceutical Preparations